DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT
$1,754,345,480
| Recipient | MODERNATX, INC. UEI WJYNZ8AK2D47 |
|---|---|
| Award ID | 75A50120C00034 |
| Award amount | $1,754,345,480 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING |
| PSC | AN11 |
| Start date | Apr 3, 2020 |
| End date | Aug 31, 2023 |
| Place of performance | CAMBRIDGE, MA |
| Record updated | Jun 18, 2024 |
View the official award record
More awards won by MODERNATX, INC.
100M SARS-COV-2 MRNA-1273 VACCINE DOSES
Department of Defense · $8,204,906,278 · Aug 11, 2020
MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF
Department of Health and Human Services · $72,971,523 · Sep 1, 2016
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids